Changes in body weight and body composition in patients with active rheumatoid arthritis aged 65+ treated with 2-year low-dose add-on prednisolone in the randomised double-blind placebo-controlled GLORIA trial

OBJECTIVES: To investigate the effect of 2 years of add-on prednisolone 5 mg/day on body weight and composition in patients with active rheumatoid arthritis (RA) aged 65+ and the relation with disease activity. METHODS: The Glucocorticoid Low-dose Outcome in RheumatoId Arthritis trial, a pragmatic,...

Descripción completa

Detalles Bibliográficos
Autores principales: Güler-Yüksel, Melek, Kuijper, Martijn, Bos, Reinhard, Molenaar, Esmeralda, Emmering, Jasper, Eshuis, Sylvia, Human, Adams, Reimann, Floor, Boers, Maarten, Kok, Marc R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314614/
https://www.ncbi.nlm.nih.gov/pubmed/37349120
http://dx.doi.org/10.1136/rmdopen-2022-002905

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314614/
https://www.ncbi.nlm.nih.gov/pubmed/37349120
http://dx.doi.org/10.1136/rmdopen-2022-002905

Ejemplares similares